<!-- S31 — Romosozumabe no SUS (posição 22) -->
<section
  class="slide"
  data-slide=""
  data-title="Romosozumabe no SUS"
  id="slide-31"
  style="padding: 36px 48px; background: var(--bg)"
>
  <div style="height: 100%; display: flex; flex-direction: column">
    <!-- Title -->
    <h1
      style="
        font-size: 38px;
        font-weight: 800;
        color: var(--navy);
        line-height: 1.1;
        margin: 0 0 4px 0;
        letter-spacing: -0.01em;
      "
    >
      Romosozumabe no SUS: indicação ampliada, alerta CV mantido
    </h1>
    <p style="font-size: 15px; font-weight: 400; color: rgba(var(--navy-rgb), 0.42); margin: 0 0 18px 0">
      Portaria SECTICS/MS n.40, 2024 — PCDT Osteoporose 2025
    </p>

    <!-- Top strip: 2 compact alert cards -->
    <div style="display: flex; gap: 14px; margin-bottom: 14px">
      <!-- Black Box -->
      <div
        style="
          flex: 1;
          background: var(--white);
          border: 1.5px solid rgba(var(--navy-rgb), 0.12);
          border-left: 4px solid var(--navy);
          border-radius: 12px;
          padding: 16px 20px;
          display: flex;
          align-items: flex-start;
          gap: 14px;
        "
      >
        <span style="display: inline-block; background: var(--navy); color: var(--white); font-size: 9px; font-weight: 700; letter-spacing: 0.1em; text-transform: uppercase; padding: 4px 8px; border-radius: 4px; white-space: nowrap; flex-shrink: 0">BLACK BOX</span>
        <p style="font-size: 14px; color: rgba(var(--navy-rgb), 0.65); margin: 0; line-height: 1.45">
          <strong style="color: var(--navy)">Risco CV:</strong> contraindicado se IAM/AVC nos últimos <strong style="color: var(--navy)">12 meses</strong>. Avaliar risco CV antes.
        </p>
      </div>

      <!-- Atualização -->
      <div
        style="
          flex: 1;
          background: var(--white);
          border: 1.5px solid var(--border);
          border-left: 4px solid var(--teal);
          border-radius: 12px;
          padding: 16px 20px;
          display: flex;
          align-items: flex-start;
          gap: 14px;
        "
      >
        <span style="display: inline-block; background: var(--teal); color: var(--white); font-size: 9px; font-weight: 700; letter-spacing: 0.1em; text-transform: uppercase; padding: 4px 8px; border-radius: 4px; white-space: nowrap; flex-shrink: 0">2024/25</span>
        <p style="font-size: 14px; color: rgba(var(--navy-rgb), 0.65); margin: 0; line-height: 1.45">
          <strong style="color: var(--navy)">Indicação ampliada:</strong> osteoporose grave + falha terapêutica, <strong style="color: var(--navy)">sem limite etário</strong>. Anexar Portaria 40 + PCDT ao LME.
        </p>
      </div>
    </div>

    <!-- Main area: 2 columns -->
    <div style="display: flex; gap: 14px; flex: 1; min-height: 0">

      <!-- Left: Elegibilidade -->
      <div
        style="
          flex: 1;
          background: var(--white);
          border: 1.5px solid var(--border);
          border-radius: 14px;
          padding: 24px 26px;
          display: flex;
          flex-direction: column;
          justify-content: space-between;
        "
      >
        <!-- Content group -->
        <div>
          <span style="display: inline-block; background: rgba(var(--navy-rgb), 0.08); color: rgba(var(--navy-rgb), 0.55); font-size: 10px; font-weight: 700; letter-spacing: 0.1em; text-transform: uppercase; padding: 4px 10px; border-radius: 4px; margin-bottom: 18px; width: fit-content">ELEGIBILIDADE SUS</span>

          <div style="display: flex; flex-direction: column; gap: 16px">
            <p style="font-size: 17px; color: var(--navy); margin: 0; line-height: 1.55">
              <span style="color: var(--teal); font-weight: 700; font-size: 18px">•</span> Mulher pós-menopausa com osteoporose grave
            </p>
            <p style="font-size: 17px; color: var(--navy); margin: 0; line-height: 1.55">
              <span style="color: var(--teal); font-weight: 700; font-size: 18px">•</span> Sem IAM/AVC nos últimos 12 meses
            </p>
            <p style="font-size: 17px; color: var(--navy); margin: 0; line-height: 1.55">
              <span style="color: var(--teal); font-weight: 700; font-size: 18px">•</span> Falha terapêutica: ≥ 2 fraturas sob tratamento
            </p>
            <p style="font-size: 17px; color: var(--navy); margin: 0; line-height: 1.55">
              <span style="color: var(--teal); font-weight: 700; font-size: 18px">•</span> Risco muito alto de fratura por fragilidade
            </p>
            <p style="font-size: 17px; color: var(--navy); margin: 0; line-height: 1.55">
              <span style="color: var(--teal); font-weight: 700; font-size: 18px">•</span> 12 meses romo → bisfosfonato sequencial (PCDT)
            </p>
          </div>
        </div>

        <p style="font-size: 13px; color: rgba(var(--navy-rgb), 0.42); margin: 0; padding-top: 14px; border-top: 1.5px solid var(--border); line-height: 1.45; font-style: italic">
          Dose: 210 mg SC/mês × 12 meses. CEAF — aquisição federal.
        </p>
      </div>

      <!-- Right: Eficácia -->
      <div
        style="
          flex: 1;
          background: var(--white);
          border: 1.5px solid var(--border);
          border-radius: 14px;
          padding: 24px 26px;
          display: flex;
          flex-direction: column;
          justify-content: space-between;
        "
      >
        <!-- Content group -->
        <div>
          <span style="display: inline-block; background: rgba(var(--navy-rgb), 0.08); color: rgba(var(--navy-rgb), 0.55); font-size: 10px; font-weight: 700; letter-spacing: 0.1em; text-transform: uppercase; padding: 4px 10px; border-radius: 4px; margin-bottom: 16px; width: fit-content">EFICÁCIA — ARCH (24 m)</span>

          <!-- Fx vertebral -->
          <div style="display: flex; align-items: baseline; gap: 12px; margin-bottom: 6px">
            <span style="font-size: 2.8vw; font-weight: 800; color: var(--teal)">−48%</span>
            <span style="font-size: 14px; color: rgba(var(--navy-rgb), 0.55)">fx vertebral</span>
          </div>
          <p style="font-size: 13px; color: rgba(var(--navy-rgb), 0.5); margin: 0 0 16px 0; line-height: 1.4">
            6,2% vs 11,9% · <strong style="color: var(--navy)">NNT 18</strong> <span style="font-size: 11.5px">(IC 95% 13-25)</span>
          </p>

          <!-- Fx quadril -->
          <div style="display: flex; align-items: baseline; gap: 12px; margin-bottom: 6px">
            <span style="font-size: 2.8vw; font-weight: 800; color: var(--teal)">−38%</span>
            <span style="font-size: 14px; color: rgba(var(--navy-rgb), 0.55)">fx quadril</span>
          </div>
          <p style="font-size: 13px; color: rgba(var(--navy-rgb), 0.5); margin: 0 0 20px 0; line-height: 1.4">
            2,0% vs 3,2% · HR 0,62 (0,42-0,92) · <strong style="color: var(--navy)">NNT 84</strong>
          </p>

          <div style="height: 1px; background: rgba(var(--navy-rgb), 0.08); margin: 4px 0 4px 0"></div>

          <!-- FRAME DMO -->
          <p style="font-size: 11px; font-weight: 600; color: rgba(var(--navy-rgb), 0.38); margin: 0 0 8px 0; text-transform: uppercase; letter-spacing: 0.06em">FRAME — ganho DMO em 12 m</p>
          <div style="display: flex; gap: 28px">
            <div>
              <span style="font-size: 2.2vw; font-weight: 800; color: var(--navy)">+13%</span>
              <p style="font-size: 12px; color: rgba(var(--navy-rgb), 0.5); margin: 2px 0 0 0">coluna (LS)</p>
            </div>
            <div>
              <span style="font-size: 2.2vw; font-weight: 800; color: var(--navy)">+7%</span>
              <p style="font-size: 12px; color: rgba(var(--navy-rgb), 0.5); margin: 2px 0 0 0">quadril total</p>
            </div>
          </div>
        </div>

        <!-- Mecanismo -->
        <p style="font-size: 13px; color: rgba(var(--navy-rgb), 0.42); margin: 0; padding-top: 14px; border-top: 1.5px solid var(--border); line-height: 1.45; font-style: italic">
          Anti-esclerostina → ↑formação + ↓reabsorção. Efeito dual. Janela: 12 m.
        </p>
      </div>
    </div>

    <!-- Navy bottom bar -->
    <div
      style="
        margin-top: 14px;
        background: var(--navy);
        border-radius: 12px;
        padding: 14px 24px;
        display: flex;
        align-items: center;
        gap: 16px;
      "
    >
      <span style="display: inline-block; background: var(--gold); color: var(--navy); font-size: 11px; font-weight: 800; padding: 4px 12px; border-radius: 6px; white-space: nowrap">Na prática</span>
      <p style="font-size: 14px; color: rgba(255,255,255,0.92); margin: 0; line-height: 1.4">
        Romosozumabe é o anabólico <strong style="color: var(--gold)">mais potente disponível no SUS</strong> — mas exige
        triagem CV rigorosa e plano de sequência obrigatório.
      </p>
    </div>

    <!-- Footnote -->
    <p style="font-size: 11px; font-style: italic; color: rgba(var(--navy-rgb), 0.35); margin: 6px 0 0 0">
      ARCH — Saag et al., NEJM 2017 · FRAME — Cosman et al., NEJM 2016 · Portaria SECTICS/MS n.40, 2024
    </p>
  </div>
</section>
